ChemicalBook >> CAS DataBase List >>TAK875

TAK875

CAS No.
1000413-72-8
Chemical Name:
TAK875
Synonyms
CS-54;TAK875;Fasiglifam;TAK-875,TAK875;TAK-875, >=98%;TAK875 USP/EP/BP;TAK-875(Fasiglifam);FASIGLIFAM (TAK-875);TAK-875; TAK875; TAK 875.;[(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-bi...
CBNumber:
CB52534865
Molecular Formula:
C29H32O7S
Molecular Weight:
524.63
MDL Number:
MFCD18251445
MOL File:
1000413-72-8.mol
MSDS File:
SDS
Last updated:2023-06-08 09:02:20

TAK875 Properties

Melting point 123-127°C
Boiling point 739.1±60.0 °C(Predicted)
Density 1.252
storage temp. Refrigerator
solubility Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly)
pka 4.36±0.10(Predicted)
form Solid
color White to Off-White
FDA UNII GLP1W4JXAH

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H315-H319-H335
Precautionary statements  P261-P305+P351+P338
NFPA 704
0
2 0

TAK875 price More Price(37)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 17335 TAK-875 ≥95% 1000413-72-8 500μg $44 2024-03-01 Buy
Cayman Chemical 17335 TAK-875 ≥95% 1000413-72-8 1mg $78 2024-03-01 Buy
Cayman Chemical 17335 TAK-875 ≥95% 1000413-72-8 5mg $299 2024-03-01 Buy
Cayman Chemical 17335 TAK-875 ≥95% 1000413-72-8 10mg $426 2024-03-01 Buy
TRC T004915 TAK-875 1000413-72-8 2.5mg $55 2021-12-16 Buy
Product number Packaging Price Buy
17335 500μg $44 Buy
17335 1mg $78 Buy
17335 5mg $299 Buy
17335 10mg $426 Buy
T004915 2.5mg $55 Buy

TAK875 Chemical Properties,Uses,Production

Description

The free fatty acid receptor 1 (FFAR1; GPR40) is highly expressed in pancreatic β-cells and activated by medium and long-chain fatty acids. There is evidence of a link between FFAR1 (GPR40) and the ability of fatty acids to amplify glucose-stimulated insulin secretion, making this signaling pathway a potential target for regulating diabetes, obesity, and other metabolic disorders. TAK-875 is a selective FFAR1 (GPR40) agonist (EC50 = 26 nM) that does not exhibit activity on the related FFARs FFAR2 (GPR43) or FFAR3 (GPR41).

Uses

TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist (1,2). TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, which has the potential to improve the control of blood sugar levels with a low risk of hypoglycemia.

Uses

TAK-876 is a selective G protein-coupled receptor 40 (GPR40) agonist. TAK-876 is a novel oral medication that has been developed to improve the secretion of insulin in a glucose-dependent manner, whic h has the potential to improve the control of blood sugar levels without the risk of hypoglycemia.

Definition

ChEBI: Fasiglifam is a member of biphenyls.

in vitro

tak-875 exhibited potent agonist activity and high binding affinity to the human receptor. in addition, tak-875 showed excellent agonist potency selectivity for gpr40 receptor over other members of the ffa receptor family (for which ec50>10 μm) [1].

in vivo

tak-875 showed potent plasma glucose-lowering action and insulinotropic action during an oral glucose tolerance test in female wistar fatty rats with impaired glucose tolerance [2].

target

GPR40

References

[1] negoro n, sasaki s, mikami s, ito m, suzuki m, tsujihata y, ito r, harada a, takeuchi k, suzuki n, miyazaki j, santou t, odani t, kanzaki n, funami m, tanaka t1, kogame a, matsunaga s, yasuma t, momose y. discovery of tak-875: a potent, selective, and orally bioavailable gpr40 agonist. acs med chem lett. 2010 jun 18;1(6):290-4.
[2] leifke e, naik h, wu j, viswanathan p, demanno d, kipnes m, vakilynejad m. a multiple-ascending-dose study to evaluate safety, pharmacokinetics, and pharmacodynamics of a novel gpr40 agonist, tak-875, in subjects with type 2 diabetes. clin pharmacol ther. 2012 jul;92(1):29-39.

TAK875 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 139)Suppliers
Supplier Tel Email Country ProdList Advantage
Capot Chemical Co.,Ltd.
571-85586718 +8613336195806 sales@capotchem.com China 29797 60
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714 fandachem@gmail.com China 9352 55
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 967 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Zhengzhou Alfa Chemical Co.,Ltd
+8618530059196 sale04@alfachem.cn China 12439 58
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6313 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29525 58

View Lastest Price from TAK875 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
TAK875 USP/EP/BP pictures 2021-08-18 TAK875 USP/EP/BP
1000413-72-8
US $1.10 / g 1g 99.9% 100 Tons min Dideu Industries Group Limited

TAK875 Spectrum

TAK875 3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)- (3S)-6-[[2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]methoxy]-2,3-dihydro-3-benzofuranacetic acid TAK-875, >=98% TAK-875,TAK875 [(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-biphenylyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid (S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid Fasiglifam (S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dih FASIGLIFAM (TAK-875) CS-54 TAK-875(Fasiglifam) TAK-875; TAK875; TAK 875. [(3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid TAK875 USP/EP/BP [(3S)-6-({2',6'-Dimethyl-4'-[3-(methylsulfonyl)propoxy]-3-bi... 1000413-72-8 C29H32O7S Inhibitors